IHM
DVAX

Iguana Healthcare Management’s Dynavax Technologies DVAX Stock Holding History

Iguana Healthcare Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-140,000
Closed -$2.69M – 91
2016
Q1 		$2.69M Buy
+140,000
New +$2.83M 0.99% 32

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Iguana Healthcare Management's DVAX Position: Q2 2016 in Review

Iguana Healthcare Management sold out of Dynavax Technologies (DVAX) in Q2 2016, closing a stake of 140,000 shares — an estimated $2.69M sold.

Iguana Healthcare Management first reported a position in DVAX in Q1 2016 and held it in 1 quarter. The position peaked at $2.69M in Q1 2016. 121 funds tracked by Wall St. Rank hold DVAX as of Q2 2016.

  • Iguana Healthcare Management reported no remaining Dynavax Technologies position as of Q2 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 140,000 Dynavax Technologies shares in Q2 2016, an estimated $2.69M.
  • Iguana Healthcare Management first reported a position in Dynavax Technologies in Q1 2016 and held it in 1 quarter.
  • Iguana Healthcare Management's Dynavax Technologies position peaked at $2.69M in Q1 2016.
  • 121 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2016.

Based on Iguana Healthcare Management's 13F filing for Q2 2016, filed 15 Aug 2016.